FDA to test all heparin at U.S. border

Mar 16, 2008

The U.S. Food and Drug Administration has issued an import alert and plans to test all shipments of the drug heparin before they enter the country.

Multiple batches of heparin sold by Baxter International have been been found to contain a mysterious contaminant, The Wall Street Journal reported Friday. The contaminated product was made in a Chinese plant.

Baxter told the newspaper company officials think the contaminant comes from pig intestines used to produce the popular anti-coagulant. The company said four recent deaths may have been at least partly related to reactions to its heparin.

Five manufacturers have agreed to test all shipments of heparin and its main ingredients for contamination, the newspaper said.

Copyright 2008 by United Press International

Explore further: Johnson & Johnson plans Ebola vaccine testing

add to favorites email to friend print save as pdf

Related Stories

Heparin recall spreads in Europe

Mar 27, 2008

France, Italy and Denmark are recalling heparin after an Italian firm purchased contaminated ingredients from China, EU drug regulators said.

Recommended for you

Seaweed menace may yield new medicines

18 hours ago

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

User comments : 0